Objective:
To compare conventional nAMD subtypes with a classification based on drusen and pachychoroid features for predicting long-term visual and atrophic outcomes.
Approach:
- Study design: Retrospective cohort study of 120 treatment-naïve eyes followed for at least six years at a single center in Japan.
- Treatment and classification: All eyes received three anti-VEGF loading doses followed by pro re nata treatment. Researchers classified eyes using conventional categories and a newer system: drusen, pachychoroid, mixed, and other.
- Outcomes: The study assessed maintenance of best-corrected visual acuity (BCVA) and the prevalence of retinal pigment epithelial and outer retinal atrophy (RORA) and complete RORA (cRORA).
Key Findings:
- Overall, 71% of eyes maintained BCVA, defined as losing fewer than 15 ETDRS letters.
- Visual retention did not differ significantly among typical nAMD, PCV, and RAP under conventional classification.
- With the newer classification, 82% of pachychoroid-type eyes maintained vision, compared with 38% of drusen-type eyes.
- BCVA worsened when RORA or cRORA emerged: mean logMAR changed from 0.10 to 0.35 at RORA onset and from 0.36 to 0.82 at cRORA onset.
- At six years, cRORA prevalence was 61.5% in the drusen group and 27.2% in the pachychoroid group; final cRORA prevalence differed significantly across the newer phenotypes.
- Conventional subtypes showed no significant differences in RORA or cRORA prevalence.
Interpretation:
The study authors suggest that classification by drusen and pachychoroid features may distinguish long-term risks of vision loss and atrophy more clearly than conventional nAMD categories. They propose that differences in underlying disease biology may contribute to the observed contrast.
Limitations:
- The study was retrospective and conducted at a single Japanese center.
- Some subgroups, particularly RAP, were small.
- Different anti-VEGF agents were used during the study period.
- The authors state that prospective studies are needed to establish causality.
Conclusion:
The findings suggest that drusen- and pachychoroid-based phenotyping may provide prognostic information about long-term atrophy and vision outcomes; the authors call for prospective studies.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.